This study aims to assess and compare the functional outcomes of patients with acute ischemic stroke (AIS) eligible for tissue plasminogen activator (t‐PA) treatment who received care from either a fifth‐generation(5G) mobile stroke unit (MSU) or traditional emergency medical service (EMS). The gene discussed is PLAT; the disease is Stroke.